A&O advises Ipsen in relation to the sale of its consumer healthcare business to Mayoly Spindler
Related people
Marc Castagnede
Partner
Paris
Romy Richter
Partner
Paris
Frederic Moreau
Partner
Paris
Olivier Picquerey
Partner
Paris
Florence Ninane
Partner
Paris
Guillaume Valois
Partner
Paris
Susan Ekrami
Counsel
Paris
Laurie-Anne Ancenys
Counsel
Paris
Luc Lamblin
Counsel
Paris
Charles Del Valle
Counsel
Paris
Arthur Sauzay
Partner
Paris
Pauline Regnier
Senior Associate
Paris
Antoine Messent
Associate
Paris
Hovig Cancioglu
Associate
Paris
Noemie Bomble
Associate
Paris
Marie Coussi
Associate
Paris
Press contacts
For media enquiries relating to this topic, please contact:
Headlines in this article
Related news and insights
News: 09 February 2024
Allen & Overy advises Sartorius group on EUR1.4bn equity raising
News: 18 January 2024
News: 18 January 2024
Allen & Overy Paris has advised Ipsen on its entry into exclusive negotiations with the pharmaceutical laboratory Mayoly Spindler in relation to the divestment of its consumer healthcare (CHC) business, which includes the drugs Smecta®, Forlax®, Tanakan®, Fortrans® and various production sites.
The combination of Ipsen’s and Mayoly Spindler’s respective CHC businesses will create a global consumer healthcare platform with a critical size and the capacity to support its growth. Capza and Caravelle, two financial investors, are supporting Mayoly Spindler and will provide part of the financing required to complete this transaction, by acquiring a minority stake in the new entity.
The transaction will be submitted to the relevant employee representative bodies of Ipsen. The closing of the transaction is expected before the end of the third quarter of 2022 upon completion of regulatory and antitrust filings and customary conditions precedent.
The Allen & Overy team is led by Marc Castagnède (Partner) and Romy Richter (Partner) with Frédéric Moreau (Partner), with support from Pauline Régnier (Associate) and Antoine Messent (Associate).
The team also included Olivier Picquerey (Partner), Susan Ekrami (Counsel) and Hovig Cancioglu (Associate) on employment law aspects, Florence Ninane (Partner) and Noémie Bomble (Associate) on antitrust aspects, Laurie-Anne Ancenys (Counsel ) and Juliette Olliveaud (Associate) on IT aspects and transitional services, Luc Lamblin (Counsel) on aspects related to the control of foreign investments, Guillaume Valois (Partner) and Charles del Valle (Counsel) on tax aspects, Arthur Sauzay (Counsel) and Marie Coussi (Associate) on public and environmental law aspects, Marianne Delassaussé (Senior Consultant) on intellectual property aspects.